Patents by Inventor Robert Rowlands

Robert Rowlands has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250026813
    Abstract: The present invention relates to antibodies that are specific for SARS-CoV-2. The present invention also provides methods of treatment, uses, pharmaceutical compositions and kits comprising the antibodies.
    Type: Application
    Filed: October 27, 2021
    Publication date: January 23, 2025
    Inventors: Paul Kellam, Anne Palser, Volker Germaschewski, Simon James Watson, Benjamin David Grimshaw, Spela Binter, Jaroslaw Michal Szary, Margot Billaud, Robert Rowlands, Aishwarya Krishna, Huan-Chun Lin, Cheng-Yuan Yang, Li-Ying Liou
  • Publication number: 20240294651
    Abstract: The invention relates to antibodies or antigen-binding fragments thereof which specifically bind to CXCR4. The invention also relates to said antibodies for use in therapy, for use in treating cancer, and for use in treating a solid tumor. The invention also relates to pharmaceutical compositions comprising said antibodies, nucleic acids that encode said antibodies, vectors comprising said nucleic acids, and host cells comprising said nucleic acids or vectors.
    Type: Application
    Filed: January 29, 2024
    Publication date: September 5, 2024
    Applicant: KYMAB LIMITED
    Inventors: Margot BILLAUD, Robert ROWLANDS, John Matthew MCCOURT, Matthew Stephen WAKE, Morgane Marie LECOINTRE, Matthew Joseph BARNES, Catherine Jane HUTCHINGS, Kirstie BENNETT, Lisa STOTT
  • Publication number: 20240158502
    Abstract: Antibodies that bind ICOS (Inducible T cell Co-Stimulator). Therapeutic use of anti-ICOS antibodies for modulating the ratio between regulatory T cells and effector T cells, to stimulate the immune system of patients, including use in treating cancers. Methods of producing anti-ICOS antibodies, including species cross-reactive antibodies, using transgenic knock-out mice.
    Type: Application
    Filed: November 1, 2023
    Publication date: May 16, 2024
    Inventors: Richard Charles Alfred SAINSON, Stephen John ARKINSTALL, Jamie Iain CAMPBELL, Mohammed Hanif ALI, E-Chiang LEE, Matthew John MCCOURT, Volker GERMASCHEWSKI, Ian KIRBY, Miha KOSMAC, Nahida PARVEEN, Robert ROWLANDS, Gwenoline BORHIS
  • Patent number: 11858996
    Abstract: Antibodies that bind ICOS (Inducible T cell Co-Stimulator). Therapeutic use of anti-ICOS antibodies for modulating the ratio between regulatory T cells and effector T cells, to stimulate the immune system of patients, including use in treating cancers. Methods of producing anti-ICOS antibodies, including species cross-reactive antibodies, using transgenic knock-out mice.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: January 2, 2024
    Assignee: KYMAB LIMITED
    Inventors: Richard Charles Alfred Sainson, Stephen John Arkinstall, Jamie Iain Campbell, Mohammed Hanif Ali, E-Chiang Lee, Matthew John McCourt, Volker Germaschewski, Ian Kirby, Miha Kosmac, Nahida Parveen, Robert Rowlands, Gwenoline Borhis
  • Patent number: 6126073
    Abstract: A transaction printer includes the MICR encoding of indicia at a precise location called the amount field. In order to accomplish this, an optical sensor is provided in a check processing machine at a point-of-sale to detect the edge of the check and stage it at a known location from the thermal, MICR print head. A clutch mechanism is used to engage the print head with a platen and to engage a read head with the check, so that indicia can be sequentially imprinted and read within the check processing machine in a single, sequential operation that moves the check from a home position to a MICR print position, and subsequently to a MICR read position.
    Type: Grant
    Filed: August 7, 1998
    Date of Patent: October 3, 2000
    Assignee: Axiohm Transaction Solutions, Inc.
    Inventor: Robert Rowlands